PRE Prenetics Global
- 5.7600
- -0.0800-1.37%
- 6.0000
- +0.2400+4.17%
Prenetics Global News
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS guidance.
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersCatheter Precision (AMEX:VTAK) shares moved upwards by 27.8% to $0.58 during Wednesday's regular session. The company's market cap stands at $4.4 million. Prenetics Global (NASDAQ:PRE) stock mo
Immutep, Capricor Therapeutics, Cyclacel Pharmaceuticals Among Healthcare Movers
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Prenetics Global Price Target Cut to $9.00/Share From $10.00 by Cantor Fitzgerald
Prenetics Global Price Target Cut to $9.00/Share From $10.00 by Cantor Fitzgerald
Prenetics Global Is Maintained at Overweight by Cantor Fitzgerald
Prenetics Global Is Maintained at Overweight by Cantor Fitzgerald
Express News | Cantor Fitzgerald Maintains Overweight on Prenetics Global, Lowers Price Target to $9
Prenetics Global Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/04/2024 152.1% Cantor Fitzgerald $10 → $9 Maintains Overweight 09/26/2023 12.04% Cantor Fitzgerald → $4
Prenetics Global GAAP EPS of -$1.49, Revenue of $5.43M
Prenetics Global: Q4 Earnings Insights
Prenetics Global (NASDAQ:PRE) reported its Q4 earnings results on Monday, April 1, 2024 at 07:30 AM.Here's what investors need to know about the announcement.EarningsPrenetics Global beat estimated ea
Prenetics Global Q4 Adjusted EPS $(0.51) Beats $(0.75) Estimate, Sales $5.43M May Not Be Comparable To $17.60M Estimate
Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.75) by 32 percent. This is a 139.23 percent decrease over earnings of $1.3
Earnings Flash (PRE) PRENETICS LIMITED Reports Q4 Revenue $5.4M
07:35 AM EDT, 04/01/2024 (MT Newswires) -- Earnings Flash (PRE) PRENETICS LIMITED Reports Q4 Revenue $5.4M
Prenetics Global 4Q Rev $5.43M >PRE
Prenetics Global 4Q Rev $5.43M >PRE
Press Release: Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersStoke Therapeutics (NASDAQ:STOK) stock moved upwards by 71.8% to $11.16 during Tuesday's regular session. The company's market cap stands at $498.5 million. The company's, Q4 earnings came out
Prenetics Partners Metavisionaries for Space Health Research Initiative
Prenetics Announces MOU For A Strategic Investment And 5-Year Research Collaboration With Metavisionaries To Pioneer R&D On The International Space Station
Initial research project is with NDORMS, Botnar Research Institute, University of Oxford, focusing on accelerated aging in spaceDr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley,
Prenetics Global Files to Sell 1.48M Class A Shares for Holders
Prenetics Global Limited's (NASDAQ:PRE) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Those holding Prenetics Global Limited (NASDAQ:PRE) shares would be relieved that the share price has rebounded 30% in the last thirty days, but it needs to keep going to repair the recent damage it has caused to investor portfolios.
Analysis
Price Target
No Data
